A detailed history of Becker Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Becker Capital Management Inc holds 15,252 shares of ABBV stock, worth $2.94 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
15,252
Previous 15,535 1.82%
Holding current value
$2.94 Million
Previous $3.07 Million 11.64%
% of portfolio
0.09%
Previous 0.1%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$164.99 - $203.87 $46,692 - $57,695
-283 Reduced 1.82%
15,252 $2.71 Million
Q3 2024

Nov 08, 2024

BUY
$163.84 - $199.33 $114,032 - $138,733
696 Added 4.69%
15,535 $3.07 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $15,788 - $18,437
-102 Reduced 0.68%
14,839 $2.55 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $43,630 - $49,713
273 Added 1.86%
14,941 $2.72 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $866,192 - $975,536
-6,295 Reduced 30.03%
14,668 $2.27 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $26,851 - $31,084
-201 Reduced 0.95%
20,963 $3.12 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $66,785 - $83,109
504 Added 2.44%
21,164 $2.85 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $225,302 - $259,469
1,558 Added 8.16%
20,660 $3.29 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $28,491 - $34,169
-206 Reduced 1.07%
19,102 $3.09 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $37,310 - $42,792
278 Added 1.46%
19,308 $2.59 Million
Q2 2022

Aug 04, 2022

BUY
$137.62 - $174.96 $157,437 - $200,154
1,144 Added 6.4%
19,030 $2.92 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $5,543 - $6,877
-42 Reduced 0.23%
17,886 $2.9 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $56,723 - $71,771
528 Added 3.03%
17,928 $2.43 Million
Q3 2021

Oct 14, 2021

SELL
$106.4 - $120.78 $11,065 - $12,561
-104 Reduced 0.59%
17,400 $1.88 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $19,569 - $21,801
186 Added 1.07%
17,504 $1.97 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $7,570 - $8,333
74 Added 0.43%
17,318 $1.87 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $25,193 - $34,013
313 Added 1.85%
17,244 $1.85 Million
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $99,397 - $116,660
-1,157 Reduced 6.4%
16,931 $1.48 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $391,355 - $523,692
5,334 Added 41.82%
18,088 $1.78 Million
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $5,353 - $8,116
83 Added 0.66%
12,754 $972,000
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $70,038 - $87,632
971 Added 8.3%
12,671 $1.12 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $118,717 - $142,732
-1,885 Reduced 13.88%
11,700 $886,000
Q2 2019

Aug 08, 2019

BUY
$65.7 - $83.98 $18,658 - $23,850
284 Added 2.14%
13,585 $988,000
Q1 2019

May 08, 2019

SELL
$77.14 - $90.79 $5,014 - $5,901
-65 Reduced 0.49%
13,301 $1.07 Million
Q4 2018

Feb 04, 2019

SELL
$77.85 - $96.01 $106,654 - $131,533
-1,370 Reduced 9.3%
13,366 $1.23 Million
Q3 2018

Nov 05, 2018

BUY
$88.91 - $98.84 $25,517 - $28,367
287 Added 1.99%
14,736 $1.39 Million
Q2 2018

Aug 03, 2018

SELL
$89.78 - $106.23 $29,447 - $34,843
-328 Reduced 2.22%
14,449 $1.34 Million
Q1 2018

May 07, 2018

BUY
$92.01 - $123.21 $558,960 - $748,500
6,075 Added 69.81%
14,777 $1.4 Million
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $135,952 - $149,082
1,518 Added 21.13%
8,702 $842,000
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $134,740 - $172,105
1,929 Added 36.71%
7,184 $638,000
Q2 2017

Aug 11, 2017

BUY
N/A
5,255
5,255 $381,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $341B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Becker Capital Management Inc Portfolio

Follow Becker Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Becker Capital Management Inc with notifications on news.